Skip to main content
. 2021 Mar 9;16(3):e0248103. doi: 10.1371/journal.pone.0248103

Table 5. Favorable and unfavorable changes in the expression of significantly differential expressed proteins after metformin treatment.

significantly differential expressed proteins after metformin administration
favorable regulation: AKT3, CCND2, CD63, CD81, GFAP, IL5, IL17A, IRF4, PI3, VTCN1 (IL1B, IL2)
unfavorable regulation: CTSL, GUSB, TFRC